Stockscreener 앱 받기
0.4788
12.63%
-0.0692
전일 마감가:
$0.548
열려 있는:
$0.5218
하루 거래량:
583.33K
Relative Volume:
0.11
시가총액:
$2.51M
수익:
$735.20K
순이익/손실:
$-9.70M
주가수익비율:
-0.0011
EPS:
-435.729
순현금흐름:
$-9.80M
1주 성능:
-22.77%
1개월 성능:
-27.83%
6개월 성능:
-93.70%
1년 성능:
-99.72%
1일 변동 폭
$0.4625
$0.5299
1주일 범위
$0.4625
$0.6007
52주 변동 폭
$0.4625
$200.00
블루 워터 백신 Stock (ONCO) Company Profile
명칭
Onconetix Inc
전화
513-620-4101
주소
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.4788 | 2.51M | 735.20K | -9.70M | -9.80M | -435.73 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
블루 워터 백신 주식(ONCO)의 최신 뉴스
Onconetix, Inc. (ONCO) — share price and filings - Howl.link
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Five proposals face a November 10 vote as Onconetix (ONCO) asks for another reverse split. - Stock Titan
Onconetix (NASDAQ: ONCO) must clear a cash hurdle to close its Realbotix takeover - Stock Titan
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - Stock Titan
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - The Manila Times
Onconetix Provides $2.5 Million Bridge Financing to Realbotix Ahead of Pending Acquisition - Quiver Quantitative
Onconetix Inc (NASDAQ: ONCO) Share Price, ONCO Stock News, ONCO Share Price & Updates - Kalkine
Could Onconetix (NASDAQ:ONCO) Face More Volatility on Nasdaq? - Kalkine Media
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
Onconetix Inc Peer Comparison – Compare with Others - Value Research
Onconetix, Inc. SEC Filing (Sep 4, 2026) - Stock Titan
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - Yahoo Finance
Humanoid robot presenters get live trial as Onconetix (NASDAQ: ONCO) pursues Realbotix buyout - Stock Titan
Onconetix (NASDAQ: ONCO) flags going concern as 100M-share resale filed - Stock Titan
Onconetix, Inc. (ONCO) Stock Price & News - syfe.com
Onconetix Inc Key Financial Ratios – Valuation, Profitability & More - Value Research
Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingReturn On Assets - dars.gov.et
Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingGuidance Downgrade Alert - vinanet.vn
Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingDividend Earnings Report - dars.gov.et
Onconetix (ONCO) flags going concern risk as cash burn, impairments mount - Stock Titan
Onconetix, Inc. (ONCO) Debt 2025 - Stock Titan
Onconetix (NASDAQ: ONCO) resale filing covers 100M shares tied to PIPE - Stock Titan
Realbotix Q3 Results: Revenue Falls 40%, Loss Widens Amid Scaling - scanx.trade
Realbotix Plans Online-Only Robot Line With Buyer Deposits in 2026 - Stock Titan
Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - The Manila Times
Onconetix (ONCO) outlines Realbotix all-stock acquisition and humanoid robot TV role - Stock Titan
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - GlobeNewswire
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - Yahoo Finance
Onconetix subsidiary appoints co-founder to board - Investing.com
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Nigeria
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Canada
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com South Africa
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - The Manila Times
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com UK
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - Caledonian Record
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - GlobeNewswire
ONCO Q1 2025 Earnings: Positive EPS of $0.25 Marks a Notable Bottom-Line QuarterBanking Earnings Report - vinanet.vn
Onconetix Inc (ONCO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Onconetix Secures Major PIPE and Equity Facility Financing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Onconetix (NASDAQ: ONCO) adds $750,000,000 ELOC and $30,249,600 PIPE - Stock Titan
Onconetix (ONCO) 13G: Keystone Capital reports 6.1% beneficial stake - Stock Titan
Onconetix Inc. (ONCO) Gains 3.46% as Shares Approach Resistance at $0.89Factor Timing - dars.gov.et
Onconetix Inc (ONCO) Balance Sheet - TradingKey
Onconetix Inc. (ONCO) Gains 3.46% as Shares Approach Resistance at $0.89Intraday Trade Ideas - vinanet.vn
Onconetix Inc (ONCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Onconetix Inc (ONCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
블루 워터 백신 (ONCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
블루 워터 백신 주식 (ONCO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Apr 20 '26 |
Sale |
0.75 |
94,462 |
70,846 |
83,359 |
| HRT FINANCIAL LP | 10% Owner |
Apr 17 '26 |
Buy |
0.73 |
34,636 |
25,284 |
177,821 |
| HRT FINANCIAL LP | 10% Owner |
Apr 16 '26 |
Sale |
0.73 |
53,867 |
39,323 |
143,185 |
| HRT FINANCIAL LP | 10% Owner |
Apr 15 '26 |
Buy |
0.76 |
92,554 |
70,341 |
197,052 |
| HRT FINANCIAL LP | 10% Owner |
Apr 14 '26 |
Buy |
0.77 |
74,350 |
57,250 |
104,498 |
4.22%
자본화:
|
볼륨(24시간):